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Background & Aims—Alcoholic steatohepatitis (ASH) is the progressive form of alcoholic 
liver disease and may lead to cirrhosis and hepatocellular carcinoma. We studied mouse models 
and human tissues to identify molecules associated with ASH progression, and focused on mouse 
fat-specific protein 27 (FSP-27)/human cell death-inducing DFF45-like effector C (CIDEC) 
protein, which is expressed in white adipose tissues and promotes formation of fat droplets.
Methods—C57BL/6N mice or mice with hepatocyte-specific disruption of Fsp27 (Fsp27Hep−/− 
mice) were fed the Lieber-Decarli ethanol liquid diet (5% ethanol) for 10 days to 12 weeks, 
followed by 1 or multiple binges of ethanol (5 or 6 g/kg) during the chronic feeding. Some mice 
were given an inhibitor of the peroxisome proliferator-activated receptor-γ (PPARG) (GW9662). 
Adenoviral vectors were used to express transgenes or small hairpin (sh) RNAs in cultured 
hepatocytes and in mice. Liver tissue samples were collected from ethanol-fed mice or from 31 
patients with alcoholic hepatitis (AH) with biopsy-proved ASH and analyzed by histologic, 
immunohistochemical, transcriptome, immunoblot, and real-time PCR analyses.
Results—Chronic-plus-binge ethanol feeding of mice, which mimics the drinking pattern of 
patients with AH, produced severe ASH and mild fibrosis. Microarray analyses revealed similar 
alterations in expression of many hepatic genes in ethanol-fed mice and humans with ASH, 
including upregulation of mouse Fsp27 (also called Cidec) and human CIDEC. Fsp27Hep−/− mice 
and mice given injections of adenovirus-Fsp27shRNA had markedly reduced ASH following 
chronic-plus-binge ethanol feeding. Inhibition of PPARG and cyclic AMP-responsive element 
binding protein H (CREBH) prevented the increases in Fsp27α and FSP27β mRNAs, respectively, 
and reduced liver injury in this chronic-plus-binge ethanol feeding model. Overexpression of 
FSP27 and ethanol exposure had synergistic effects in inducing production of mitochondrial 
reactive oxygen species and damage to hepatocytes in mice. Hepatic CIDEC mRNA expression 
was increased in patients with AH and correlated with the degree of hepatic steatosis and disease 
severity including mortality.
Conclusion—In mice, chronic-plus-binge ethanol feeding induces ASH that mimics some 
histological and molecular features observed in patients with AH. Hepatic expression of FSP27/
CIDEC is highly upregulated in mice following chronic-plus-binge ethanol feeding and in patients 
with AH; this upregulation contributes to alcohol-induced liver damage.
Keywords
lipid metabolism; endoplasmic reticulum; inflammation; translational research
Introduction
Excessive alcohol consumption is a leading cause of chronic liver diseases worldwide, 
causing a broad spectrum of illnesses, including steatosis, steatohepatitis (ASH), cirrhosis, 
and hepatocellular carcinoma.1–3 Alcoholic hepatitis (AH), a severe form of alcoholic liver 
disease (ALD), can occur in patients with undergoing ALD and a history of recent excessive 
alcohol consumption, and it is associated with high mortality.4–8 The typical histology 
findings in AH patients show severe ASH, including steatosis, hepatocyte ballooning, 
neutrophilic infiltration, Mallory-Denk hyaline inclusions, and chicken wire fibrosis.4–8 
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Despite extensive research on ALD over the last 40 years, the pathogenesis of AH remains 
obscure and little progress has been made in the management of severe AH.4–9 Slow 
progress in the field of ALD has partly resulted from a lack of experimental models of 
advanced ALD and a lack of comparative translational studies. Many animal models have 
been used for the study of ALD, but few studies could reproduce the full spectrum of human 
AH.3, 10–12 Recently, a model of short-term (10-day)-plus-binge ethanol feeding in mice 
was developed,13 which showed significant elevation of serum ALT and AST, mild steatosis 
and neutrophil infiltration, but no liver fibrosis.13 Here, we extended the chronic ethanol 
feeding period to 8–12 weeks, followed by gavage of a single or multiple doses of ethanol. 
This model induced severe ASH and mild fibrosis.
To understand the pathogenesis of AH further, we developed an integrative approach by 
comparing transcriptome data from this clinically relevant model and biopsy-proven ASH 
from AH patients, and we identified many genes that were similarly dysregulated in the 
animal model and in AH samples. Among these genes, fat-specific protein 27 (Fsp27) and 
cell death-inducing DFF45-like effector C (CIDEC) were highly upregulated in this animal 
model and in AH samples, respectively. Mouse Fsp27 gene is the human homologue of 
CIDEC, belonging to the family of CIDE proteins, which includes CIDEA, CIDEB, and 
CIDEC (human)/FSP27 (mice), and these proteins have been shown to play important roles 
in the development of metabolic disorders and nonalcoholic fatty liver disease (NAFLD) in 
addition to the regulation of cell apoptosis.14–17 FSP27 was found to be highly expressed in 
adipose tissues and to function as a lipid droplet-binding protein that promotes lipid 
accumulation in adipocytes.18, 19 While normal mouse livers express low levels of FSP27 
protein, its expression is highly upregulated in NALFD,15, 20, 21 but not in chronic ethanol 
feeding-induced fatty liver.21 In the current study, we have demonstrated that hepatic 
expression of Fsp27/CIDEC is highly upregulated in chronic-plus-binge ethanol-fed mice 
and in human AH samples. Moreover, we provide evidence suggesting that FSP27/CIDEC 
promotes ASH in chronic-plus-binge ethanol-fed mice and in human AH.
Materials and Methods
Mice
Male mice were used in all experiments except the data in supporting Fig. 3. All of the 
animal experiments were approved by the NIAAA Animal Care and Use Committee.
Ethanol Feeding Protocols
Eight- to ten-week-old male mice were subjected to several different ethanol feeding 
protocols, including short-term or chronic-plus-one binge or multiple binges, chronic, or 
acute ethanol feeding. The details are described in supporting methods.
Human Liver Samples
Thirty-one consecutive AH patients admitted to the Liver Unit (Hospital Clinic, Barcelona, 
Spain) with biopsy-proven ASH were included. The details about these samples are 
described in supporting materials. The Ethics Committee of the Hospital Clinic approved the 
study protocol, and all of the patients provided written informed consent.
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Other methods are described in supporting materials
Results
Chronic-plus-binge ethanol feeding induces more severe ASH than short-term-plus-binge 
feeding in mice
To characterize the chronic-plus-binge ethanol model, we evaluated the liver injury in male 
C57BL/6N mice fed ethanol for 10 days- to 12 weeks-plus-one binge, or for 8 weeks-plus-
multiple binges of ethanol (two binges per week for 8 weeks).
As illustrated in Figs. 1A–B, the livers from chronically ethanol-fed mice (E8w) appeared 
pale, with mixed macro- and micro-steatosis; the range of steatosis was 5–20% (the 
percentage was calculated as the number of hepatocytes with obvious lipid droplets among 
the total number of hepatocytes). In contrast, the livers from mice chronically fed ethanol for 
8–12 weeks-plus-one or multiple binges (E8w+1B, E12w+1B, E8w+nB) appeared very 
pale, with severe macrosteatosis as demonstrated by H&E staining. The range of steatosis 
was 20–80%.
Fig. 1C shows serum ALT and AST from different feeding models. Serum ALT levels were 
markedly elevated in chronic-plus-one binge-fed mice with the highest levels in E12w+1B 
and E8w+1B, followed by E4w+1B and E10d+1B groups. Interestingly, the serum AST 
levels were also markedly elevated in chronic-plus-binge ethanol-fed mice, but were 
comparable among these groups. In contrast, serum ALT and AST levels were slightly or 
not elevated in mice with pair feeding (P8w), with chronic ethanol feeding only (E10d, E8w, 
E12w), or with one or multiple binges only (1B, nB). Surprisingly, serum ALT and AST 
levels were lower in E8w+nB group compared to those in E8w+1B group (Fig. 1C). This 
may be due to the fact that E8w+1B represents acute-on-chronic liver injury while E8w+nB 
represents the mixture of acute-on-chronic and chronic liver injury model. The ongoing 
hepatocyte injury in E8w+nB was likely milder than that in E8w+1B at the time point when 
ALT and AST were measured. In addition, serum ALT and AST levels returned to basal 
levels 24 h post binge in the E8w+1B-treated mice; however, significant steatosis and 
neutrophil infiltration were still observed (supporting Fig. 1B).
We further characterized the chronic-plus-binge (E8w+1B and E8w+nB) models. As 
illustrated in Fig. 2 and supporting Fig. 2, the number of neutrophils, hepatic triglyceride 
levels, liver fibrosis (as determined by α-SMA staining, Sirus red staining, expression of 
collagens), the number of TUNEL+ hepatocytes were much greater in E8w+1B and E8w
+nB groups than those in P8w or E8w groups. Surprisingly, the elevation of these 
parameters was similar in both E8w+1B and E8w+nB groups. Although the number of 
neutrophils was similar in these two groups, the infiltration pattern was very different. In 
E8w+1B group, neutrophils diffusely infiltrated the parenchyma while in E8w+nB group, 
many neutrophil clusters were observed (Fig. 2A–B and supporting Fig. 2A). In addition, 
hepatic levels of 4-hydroxynonenal (HNE) adducts and protein nitration were highly 
elevated in E8w+1B and E8w+nB groups compared to P8w or E8w groups, with 
significantly higher levels in the E8w+nB group than in the E8w+1B group (supporting Fig. 
2). Finally, hepatic expression of several pro-inflammatory mediators were elevated in E8w
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+1B and E8w+nB mice (Fig. 2C), with higher levels of Cxcl4, Icam-1, Tnfα, IL-1β, Ly6G 
but lower levels of Trail-r2, Tnfr1 in the latter group than those in the former group (the 
details about these factors are described in supporting materials).
Mallory-Denk bodies, which are formed by the accumulation of pre-keratin filaments in 
hepatocytes, are often observed in human AH.22 Although we did not observe Mallory-Denk 
bodies in this chronic-plus-binge model, keratin 8 and keratin 18, two major components of 
Mallory-Denk bodies,22 were upregulated by ~4–8 folds with much higher in E8w+nB than 
those in E8w+1B (supporting Fig. 2B).
Ballooning degeneration of hepatocytes is considered a hallmark of ASH and often 
accompanies necrotic damage.4, 5 Such ballooning hepatocytes were not observed in the 
chronic-plus-binge model; however, the number of TUNEL+ hepatocytes was markedly 
increased in this model, although there was no difference between E8w+1B and E8w+nB 
groups (Fig. 2A and supporting. 2B).
Finally, this chronic-plus-binge ethanol feeding model worked well in female C57BL/6N 
mice, inducing significant ASH (please see details in supporting materials and supporting 
Fig. 3).
Microarray analyses show that hepatic gene profiles in E8w+1B and E8w+nB mice are 
more similar than in E10d+1B mice to those in human AH
To further study the regulation of hepatic genes after chronic-plus-binge ethanol feeding, 
microarray analyses were performed from various groups. As shown in Supporting Figs. 
4A–B, only 173 genes showed a >2-fold change in expression in E8w mice compared to 
pair-fed P8w mice (E8w vs. P8w), whereas 1253 genes showed a >2-fold change in 
expression in E8w+1B group relative to P8w group, which was much higher than the 
number of differentially regulated genes in E10d+1B group (825 genes) relative to P10d 
group. Microarray analyses of E8w+nB group revealed that the gene expression profiles 
from this group are very different from E8w+1B group, with much greater number of altered 
genes than those from E8w+1B group (supporting Figs. 4A–B).
To investigate the clinical relevance of this chronic-plus-binge ethanol model, we compared 
the gene expression profiles of these mice with those in human AH. As illustrated in 
supporting Fig. 4B, compared with human AH samples, E10d+1B, E8w+1B, and E8w+nB 
groups had 660, 1018, and 1225 genes that are similarly altered, respectively. Many of these 
differentially regulated genes were involved in lipid metabolism and hepatotoxicity 
(supporting Fig. 4C). The top 20 genes that were similarly altered in E8w+1B, E8w+nB, and 
human AH samples are listed in supporting Fig. 4D.
Chronic-plus-binge ethanol feeding upregulates hepatic Fsp27α and Fsp27β gene 
expression in mice in PPARγ- and CREBH-dependent manner, respectively
Among the most highly upregulated genes, the Fsp27 gene was upregulated by 13-fold and 
4-fold in E8w+1B and E8w+nB group, respectively, and the expression of CIDEC, the 
human homologue of Fsp27, was upregulated by 5-fold in human AH (supporting Fig. 4D). 
Real-time PCR analyses confirmed that hepatic expression of Fsp27 was elevated by 10-fold 
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after E8w+1B feeding, but only tend to increase without statistical significance after E10d
+1B or single binge (1B) feeding (Fig. 3A). In contrast, hepatic Cidea and Cideb expression 
was not upregulated in E8w+1B group (Fig. 3B). Moreover, chronic ethanol feeding alone 
(E8w) did not alter hepatic Cidea, Cideb, or Fsp27 gene expression (Fig. 3B).
Fsp27 gene exists two isoforms including Fsp27α and Fsp27β.23 Here we also demonstrated 
that the livers from pair-fed (P8w) mice expressed both Fsp27α and Fsp27β mRNAs. The 
Fsp27β mRNA is the predominant form that is 1000-fold higher than the Fsp27α mRNA 
(Fig. 3C). Both isoforms were highly upregulated in E8w+1B and E8w+nB groups with 
greater elevation in the former group than the latter group (Fig. 3C). Elevation of FSP27 
protein expression in E8w+1B mice was confirmed by western blot analysis (Fig. 3D).
Although E8w+1B feeding markedly upregulated hepatic expression of FSP27, incubation 
with up to 100 mM ethanol in vitro did not elevate FSP27 expression in primary hepatocytes 
(data not shown), suggesting ethanol does not directly upregulate hepatic FSP27 expression. 
Fsp27 gene expression is controlled by several transcription factors, including cyclic-AMP-
responsive-element binding protein H (CREBH),23 PPARγ,15 and PPARα.24 Western blot 
analysis in Fig. 3D revealed that hepatic expression of PPARγ and active nuclear form of 
CREBH-N protein was elevated after E8w+1B feeding, whereas PPARα protein was 
slightly decreased. Additionally, hepatic expression of PPARγ and CREBH-N protein was 
not altered after binge alone (supporting Fig. 5A).
CREBH is localized in the endoplasmic reticulum (ER) membrane and is activated by ER 
stress.25 To examine whether activation of CREBH-N by E8w+1B feeding was due to 
activation of ER stress, hepatic expression of ER stress protein (the immunoglobulin-heavy-
chain-binding protein [BiP]/78-kDa glucose-regulated protein [GRP78] and transcription 
factor C/EBP homologous protein [CHOP]) was measured. The results in Fig. 3D revealed 
that expression of both CHOP and BiP was significantly elevated in the E8w+1B-treated 
group, suggesting that E8w+1B feeding activates ER stress followed by activation of 
CREBH-N.
Finally, treatment of mice with the PPARγ inhibitor GW9662 reduced the hepatic 
expression of Fsp27α mRNA but not Fsp27β mRNA in E8w+1B mice; while inhibition of 
hepatic CREBH expression by using Ad-shCREBH blocked Fsp27β mRNA but not Fsp27α 
mRNA (Figs. 3E–3F).
To examine whether upregulation of FSP27 conversely affects ER stress, we examined 
hepatic expression of ER stress proteins in Fsp27 knockdown livers. As illustrated in 
supporting Fig. 5B, hepatic levels of Bip and CHOP as well as PPAR-γ and CREBH-N were 
not altered after Fsp27 knockdown. Collectively, these results indicate that activation of ER 
stress upregulates hepatic Fsp27 expression, while Fsp27 does not affect ER stress gene 
expression.
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Inhibition of Fsp27 gene expression by injection of Ad-Fsp27shRNA or genetic disruption 
ameliorates chronic-plus-binge ethanol-induced ASH
To study the function of Fsp27, we used the Ad-Fsp27shRNA to suppress Fsp27 expression 
or used hepatocyte-specific Fsp27 knockout (Fsp27Hep−/−) mice. As illustrated in Fig. 4 and 
supporting Fig. 6, E8w+1B or E8w+nB feeding-mediated induction elevation of serum ALT 
and AST, hepatic steatosis, and TUNEL+ hepatocytes were reduced in Ad-Fsp27shRNA-
treated mice and Fsp27Hep−/− mice compared to their corresponding controls. In addition, 
hepatic expression of several pro-inflammatory genes, fibrogeneic genes, and keratin genes 
was lower in Fsp27Hep−/− mice than in WT mice after E8w+nB treatment (Fig. 4F); 
however, expression of these genes was not reduced in Fsp27Hep−/− and Ad-Fsp27shRNA-
treated mice after E8w+1B challenge (supporting Figs. 7A–B). Interestingly, chronic ethanol 
feeding alone induced comparable levels of mild elevation of serum ALT and AST and 
hepatic triglyceride levels in Fsp27Hep−/− and WT mice (supporting Fig. 8).
Moreover, treatment of mice with the PPARγ inhibitor GW9662 or knockdown of Crebh by 
administration of Ad-shCREBH partially ameliorated E8w+1B-induced elevation of serum 
ALT and AST levels, but did not reduce E8w+1B-induced elevation of hepatic pro-
inflammatory mediators (Supporting Figs. 9A–D).
Ethanol and FSP27 synergistically promote mitochondrial reactive oxygen species (ROS) 
production in hepatocytes
Because induction of mitochondrial injury is an important mechanism underlying ethanol-
induced liver injury,26, 27 we wondered whether FSP27 is involved in alcohol-induced 
hepatocyte mitochondria ROS production. As illustrated in Figs. 5A–5B, hepatic levels of 
malondialdehyde (MDA) and 4-HNE (oxidative stress/lipid peroxidation markers) were 
highly elevated in E8w+1B, and this elevation was attenuated after treatment with 
Fsp27shRNA. This suggests that FSP27 promotes ethanol-induced hepatic oxidative injury.
It is generally believed that FSP27 protein is located in cytoplasm and promotes fat lipid 
droplet formation.14 However, the function of FSP27 in mitochondria has not been 
examined. MitoProt II analysis28 revealed that the FSP27 protein contains a sequence that is 
required for protein translocation into mitochondria, thus we asked whether FSP27 is located 
in mitochondria. To answer this question, we isolated cytoplasm and mitochondria from 
fresh liver tissues of E8w+1B-treated mice (those are known to express high levels of 
FSP27). Western blot analysis detected FSP27 protein in both cytoplasm and mitochondrial 
(Fig. 5C).
In addition, we overexpressed FSP27 protein in the liver or in primary hepatocytes via the 
treatment of Ad-Fsp27-HA (that contains a HA tag sequence). As illustrated in Fig. 5D and 
supporting Fig. 10A, anti-HA antibody detected the expression of FSP27-HA protein in both 
cytoplasm and mitochondria from the livers of mice infected with Ad-Fsp27-HA or in 
cultured FSP27-HA-transfected hepatocytes. Incubation with ethanol did not affect FSP27-
HA expression in cultured hepatocytes (Fig. 5D). Moreover, overexpression of Ad-Fsp27-
HA protein exacerbated the elevation of serum ALT and AST levels and decreased 
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mitochondrial contents and mitochondrial complex I activity in E8w+1B-treated mice 
(supporting Fig. 10B).
Next, we examined ROS production in cultured hepatocytes. As illustrated in Fig. 5E, 
hepatocytes from lean WT and Fsp27−/− mice produced comparable levels of ROS post 
exposure to ethanol in vitro, suggesting that endogenous FSP27 has no effects on ROS 
production in normal hepatocytes. This may be due to the fact that normal hepatocytes 
express very low levels of endogenous FSP27 and incubation with ethanol does not 
upregulate FSP27 in hepatocytes (data not shown). Exposure to ethanol in vitro or 
overexpression of FSP27 itself increased mitochondrial ROS generation in hepatocytes. The 
combination of FSP27 overexpression and ethanol exposure synergistically increased 
mitochondrial ROS generation in hepatocytes (Fig. 5E). Finally, incubation with up to 600 
mM ethanol did not cause death of Ad-control vector-treated hepatocytes, as measured by 
elevation of ALT, while as low as 100 mM ethanol caused death of Ad- FSP27-HA-treated 
hepatocytes (Fig. 5F).
To further examine the mechanism how FSP27 overexpression induces hepatocyte death in 
the presence of ethanol, we examined Bax translocation and cytochrome C release, two 
important early events in cell death. As illustrated in Fig. 5D, overexpression of Fsp27 itself 
significantly induced Bax translocation to mitochondria and cytochrome C release, which 
were further exacerbated after incubation with ethanol.
Hepatic expression of CIDEC is increased in AH patients and correlated with disease 
severity
Microarray analysis revealed that CIDEC was upregulated by 5-fold in AH samples, 
compared with healthy control livers (supporting Fig. 4). Real-time PCR analysis of CIDEC 
mRNA was conducted in a cohort of patients with AH and revealed that hepatic expression 
of CIDEC mRNA was increased by more than 40-fold in AH samples but not in chronic 
hepatitis C or compensated cirrhosis samples (Fig. 6A). Moreover, hepatic CIDEC levels 
were higher in AH patients who had higher degrees of steatosis, and this expression was 
positively correlated with the prognostic MELD score and ABIC (age, serum bilirubin, INR, 
and serum creatinine) score29 and with HVPG (hepatic venous pressure gradient)30 in AH 
patients (Figs. 6B–C). Importantly, hepatic levels of CIDEC mRNA were much higher in 
patients who died within 90 days after admission than in patients who survived (Fig. 6D). 
Finally, a Kaplan-Meier analysis was conducted to determine whether hepatic CIDEC 
mRNA expression was a good predictor of short-term mortality. As shown in Fig. 6E, 
hepatic CIDEC mRNA expression (receiver operating curve cut-off value of 37-fold 
****[2□ΔΔCt], AUROC 0.71, 95% CI [0.45–0.97]) was useful for predicting short-term 
mortality in AH patients. These findings suggest that CIDEC plays a role in promoting liver 
injury in AH and could be used as a biomarker to predict short-term mortality.
Discussion
In this paper, we developed a model of chronic-plus-binge ethanol feeding, which induced 
more severe ASH than short-term (10-day)-plus-binge model (the comparison of these 
models is summarized in supporting Table 3). By comparing transcriptome data from this 
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clinically relevant model with those from human ASH samples, we identified that FSP27/
CIDEC was highly elevated and acted as an important mediator promoting ASH in chronic-
plus-binge-fed mice and in human AH (Fig. 7).
Short-term-plus-binge vs chronic-plus-binge ethanol feeding
Compared with the shortterm E10d+1B model, the chronic E8w+1B and E8w+nB model 
induced more severe ASH and simulated some aspects of early steatohepatitis in AH 
patients, including elevation of serum ALT and AST levels, AST to ALT ratio >2, 
macrosteatosis, neutrophil infiltration, mild “chicken-wire” like fibrosis, and alterations in 
the expression of many genes related to lipid metabolism, hepatotoxicity, and inflammation. 
Although hepatic triglyceride levels, the number of neutrophils, and degree of liver fibrosis 
were comparable between E8w+1B and E8w+nB groups, there were some differences 
between the two groups described in supporting materials in detail.
In summary, E8w+1B and E8w+nB models represent a more advanced stage of ASH than 
E10d+1B model. While E8w+1B represents an acute-on-chronic liver injury, E8w+nB 
reproduces the mixture between chronic and acute-on-chronic liver injury models. Both E8w
+1B and E8w+nB models still represent early stages of ASH. Recently, a complex hybrid 
model was developed by chronically feeding a high-fat, high-cholesterol, and ethanol diet to 
mice combined with gavage administration of ethanol.12 This model simulates some features 
of severe AH. Thus, the E10d+1B, E8w+1B, E8w+nB, and the hybrid model may represent 
different stages of ASH.
Elevation of hepatic Fsp27/CIDEC in chronic-plus-binge-fed mice and human AH
By comparing the transcriptome data from E8w+1B and human AH samples, we identified 
1018 genes that were similarly regulated between these two groups. Among them, hepatic 
Fsp27 expression was highly elevated in E8w+1B-fed mice, and was also elevated in E8w
+nB mice but to a lesser extent, however, its expression was only slightly elevated in E10d
+1B and acute alcohol (1B)-fed mice, and not elevated in chronic ethanol-fed mice (this 
study and reference21). Hepatic expression of CIDEC was also upregulated in human AH 
but not in alcoholic cirrhotic livers or chronic HCV-infected livers. Collectively, these 
findings suggest that hepatic Fsp27/CIDEC is highly elevated in acute-on-chronic alcoholic 
liver injury (E8w+1B and human AH), and this elevation is less obvious in E8w+nB (a 
model mimicking mixture of acute-on-chronic and chronic) and not elevated in E8w 
(chronic injury).
The next question concerned the cause of Fsp27/CIDEC upregulation in E8w+1B mice and 
human AH. It has been well documented that hepatic expression of Fsp27 is controlled by 
CREBH,23 PPARγ,15 and PPARα.24 Both CREBH and PPARγ were upregulated in the liver 
after E8w+1B treatment, and blockage of them ameliorated hepatic expression Fsp27. This 
suggests that chronic-plus-binge ethanol feeding upregulates hepatic Fsp27 expression via 
the activation of CREBH-N and PPARγ. In addition, we found that E8w+1B treatment 
markedly activated hepatic ER-stress protein CHOP and Bip. Although we did not examine 
the link between this ER stress and FSP27 upregulation, several recent studies reported that 
activation of ER stress by various stimuli upregulated PPAR-γ, CREBH-N, and FSP27 in 
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hepatocytes.25, 31 Thus it is plausible that activation of ER stress by E8w+1B contributes to 
the hepatic FSP27 upregulation in this model via the activation of PPAR-γ and CREBH-N.
PPARγ expression was elevated after E8w+1B challenge, and treatment with a PPARγ 
antagonist partially reduced hepatic expression of Fsp27α mRNA and ameliorated elevation 
of serum ALT and AST. PPARγ was shown to promote hepatic steatosis32, 33 but to inhibit 
inflammation34 in NAFLD, and the anti-inflammatory effect is mediated by its primary 
insulin-sensitizing effect on adipose tissue.34 In contrast to NAFLD, the alcohol feeding 
model is only associated with hepatic steatosis but not obesity. Thus, PPARγ likely exerts a 
predominant pro-steatotic effect in chronic-plus-binge ethanol feeding model, and inhibition 
of PPARγ by an antagonist shows beneficial effects by ameliorating alcoholic liver injury. 
In addition, the pro-steatotic effect of PPARγ in hepatocytes is mediated via the 
upregulation of Fsp27 gene.32, 33 However, because FSP27α is a very minor form in the 
liver, which is 1000-fold lower than FSP27β expression, the downregulation of FSP27α by 
GW9662 may not or only partially account for the protective effect of the PPARγ antagonist 
GW9662 treatment in the E8w+1B model. There may be other factors, but yet not clear, also 
contribute to the amelioration of liver injury in E8w+1B mice by GW9662 treatment.
An important role of FSP27/CIDEC in acute-on-chronic ethanol-induced liver injury and 
human AH
Genetic deletion of hepatic Fsp27 gene markedly ameliorated chronic-plus-binge ethanol-
induced liver injury but not chronic ethanol-induced liver injury, suggesting that FSP27 
promotes ASH induced by chronic-plus-binge ethanol feeding but not by chronic ethanol 
feeding. The mechanisms by which FSP27 induces fat droplet formation have been 
extensively studied;14 however, how FSP27 promotes cell injury is poorly understood. One 
mechanism underlying FSP27-mediated liver injury is the induction of steatosis and 
subsequent lipotoxicity. In addition, in this study, we demonstrated that FSP27 is also 
located in hepatocyte mitochondria and together with ethanol exposure synergistically 
induce mitochondrial ROS production and subsequent hepatocyte death. Thus, direct 
induction of mitochondrial ROS production is another important mechanism by which 
FSP27 promotes alcoholic liver injury. Furthermore, we show that overexpression of FSP27 
inhibits mitochondrial complex I activity in the liver, which likely contributes to FSP27-
mediated induction of ROS in mitochondria.
CIDEC, the human homolog of FSP27, is mainly expressed in white adipose tissues, and has 
been shown to promote fat droplet formation and cell apoptosis in adipocytes.14, 16 CIDEC 
is expressed at low levels in normal healthy human livers, but is markedly upregulated in 
NAFLD.20 However, the functions of CIDEC in the pathogenesis of human liver diseases 
have not been explored. In the current paper, we demonstrated that CIDEC mRNA was 
upregulated by approximately 40-fold in human AH compared with normal healthy controls. 
Although we demonstrated that hepatic FSP27 is highly elevated in severe AH, whether 
hepatic FSP27 is also upregulated in patients with milder forms of ASH or fatty liver 
deserves further investigation.
The upregulation of CIDEC mRNA was positively correlated with the degree of hepatic 
steatosis, the severity of disease, and the mortality of AH patients. Because knockdown of 
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FSP27 ameliorates chronic-plus-binge ethanol-induced ASH in mice, we speculate that 
upregulation of CIDEC contributes to the pathogenesis in AH patients by promoting 
steatosis and hepatocyte damage, and subsequently inducing neutrophilic infiltration.
Roles of FSP27 in E8w+1B and E8w+nB-induced liver injury
Hepatic FSP27 was upregulated in both E8w+1B and E8w+nB models with much higher 
levels in E8w+1B than in E8w+nB. Knockdown of FSP27 ameliorated the elevation of 
serum ALT and AST, and steatosis in both models. However, genetic disruption of the 
Fsp27 gene reduced expression of inflammatory genes and collagens in E8w+nB model but 
not in E8w+1B model. This indicates that the wound healing response in E8w+nB and E8w
+1B models is FSP27-dependent and –independent, respectively (Fig. 7). E8w+1B 
represents an acute-on-chronic liver injury model, in which hepatic FSP27 is only markedly 
upregulated post 1B treatment in the chronic (8w) ethanol-fed mice. This transient FSP27 
elevation likely induces steatosis and liver injury but not inflammation and fibrosis in E8w
+1B model. In contrast, E8w+nB represents a mixture of chronic and acute-on-chronic liver 
injury, in which hepatic FSP27 elevation is prolonged. This sustained FSP27 expression in 
hepatocytes likely causes the chronic liver injury and inflammation, and may subsequently 
induce fibrosis in E8w+nB model (Fig. 7).
Although genetic disruption of the Fsp27 gene in hepatocytes did not affect hepatic collagen 
expression in E8w+1B model, inhibition of Fsp27 by administration of adeno-shFsp27 
enhanced hepatic collagen expression (supporting Fig. 7). It is plausible that injection of 
adeno-shFsp27 downregulates Fsp27 expression not only in hepatocytes but also in stellate 
cells, and that elevated hepatic collagen expression by Ad-shFsp27 was due to inhibition of 
Fsp27 in stellate cells. In fact, FSP27 can directly inhibit stellate cell activation and liver 
fibrosis.35
Conclusion: in the current study, we developed an integrative biological approach by 
analyzing transcriptome data from chronic-plus-binge ethanol-fed mice and human AH, and 
we demonstrated that FSP27/CIDEC plays important roles in promoting ASH in this mouse 
model and in AH patients. This approach could be used in the future to identify and 
investigate other important mediators that may contribute to the pathogenesis of ASH, and it 
will likely facilitate the discovery of novel therapeutic targets for the treatment of this severe 
clinical condition.
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Refer to Web version on PubMed Central for supplementary material.
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ABIC age, serum bilirubin, INR, and serum creatinine score
AH alcoholic hepatitis
ALD alcoholic liver disease
ASH alcoholic steatohepatitis
BiP immunoglobulin-heavy-chain-binding protein (BiP)
CHOP transcription factor C/EBP homologous protein
CIDE-C cell death-inducing DFF45-like effector C
CREBH cyclic-AMP-responsive- element binding protein H
E10d+1B short-term (10 days) plus single binge ethanol feeding
E4W+1B, E8w+1B, 
and E12W+1B
long-term (4, 8 and 12 weeks) plus single binge ethanol feeding, 
respectively
E8w+nB long-term (8 weeks) plus multiple binges of ethanol feeding
FSP27 fat-specific protein 27
GRP78 78-kDa glucose-regulated protein
HVPG hepatic venous pressure gradient
PPARγ peroxisome proliferator-activated receptor γ
ROS reactive oxygen species.
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Figure 1. Chronic-plus-binge ethanol feeding induces ASH
A–C, Eight- to ten-week-old male C57BL6N mice were fed a liquid diet containing 5% 
ethanol for 10 days or for 4 to 12 weeks-plus-one binge (E10d+1B, E4-12w+1B) or with 
multiple binges (E8w+nB), for 8 weeks without a binge (E8w), or pair-fed (P8w); the mice 
were euthanized at 9 hours post-binge. (A) Representative images of livers. (B) 
Representative images of H&E staining. (C) Serum ALT and AST levels. Values represent 
the mean ± SEM (n=5–30 mice per group). *P<0.05 in comparison with E8w; #P<0.05 as 
indicated.
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Figure 2. Characterization of chronic-plus-binge feeding model (E8w+1B and E8w+nB)
(A) Representative photographs (200x) of various stainings of liver tissues. (B) Neutrophil 
infiltration per field (100×), number of inflammatory foci per 100 fields, Sirius red positive 
area, and hepatic expression of collagens were determined. (C) Real-time quantitative PCR 
analyses of pro-inflammatory genes. *P<0.05, **P<0.01, ***P<0.001 in E8w+1B and E8w
+nB in comparison with P8w or E8w. #P<0.05 as indicated. (n=5–8 mice per group).
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Figure 3. Chronic-plus-binge feeding upregulates hepatic Fsp27α and Fsp27β expression through 
PPARγ- and CREBH-N-dependent mechanisms, respectively
Mice from different feeding models were used. (A, B, C) Real-time PCR analyses of liver 
tissues. (D) Western blot analyses of liver tissues. The density of the protein bands was 
quantified on the right panel. (E, F) Mice were fed E8w+1B, and vehicle or the PPAR-γ 
inhibitor GW9662 was administered i.p. 15 minutes before the binge treatment, or infected 
with Ad-control-shRNA or Ad-shCREBH 5 days before ethanol gavage. Hepatic Fsp27α 
and Fsp27β mRNA levels were determined by real-time PCR analyses. *P<0.05, **P<0.01, 
***P<0.001; #P<0.05 as indicated. (n=3–12 mice per group).
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Figure 4. Inhibition of hepatic Fsp27 ameliorates chronic-plus-binge ethanol-induced liver injury
(A–C) Mice were fed E8w+1B and administered Ad-control-shRNA or Ad-shFsp27 for the 
final 5 days. Real-time PCR analyses, serum ALT and AST levels, and representative H&E 
staining of the liver are shown. (D–F) Fsp27Hep−/− and WT mice were fed E8w+1B or E8w
+nB. Mice were euthanized 9 hours post the last binge. Serum ALT and AST levels, liver 
triglyceride levels, representative H&E staining (E8w+1B), and real-time PCR analyses are 
shown. *P<0.05, **P<0.01, ***P<0.001 as indicated. (n=6–8 mice per group).
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Figure 5. Ethanol and FSP27 synergistically induce mitochondrial ROS production and 
hepatocyte death
(A, B, C) Mice were fed E8w+1B and administered Ad-control-shRNA or Ad-shFsp27 for 
the final 5 days, and were euthanized 9 hours post binge. Liver tissues were subjected to 
MDA staining (panel A) and western blotting for 4-HNE (panel B). Cytoplasm and 
mitochondria were isolated from fresh liver tissues and subjected to western blot analysis 
(panel C). (D, E) Hepatocytes were infected with Adcontrol or Ad-Fsp27-HA for 36 hours, 
then incubated with ethanol for 6 hours. Cytoplasm and mitochondria were isolated for 
western blotting (panel D). Mitochondrial ROS generation was measured (panel E). ROS 
production was also measured in hepatocytes from WT and Fsp27Hep−/− mice (panel E). (F) 
Ad-control-vector- or Ad-Fsp27-HA-treated hepatocytes were incubated with various 
concentrations of ethanol for 6 hours, ALT levels in the supernatant were measured. 
*P<0.05, **P<0.01.
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Figure 6. Hepatic CIDEC mRNA levels are increased and positively correlated with the severity 
of disease in AH patients
(A) Real-time PCR analyses of liver samples from patients and from healthy controls. (B) 
Correlation between CIDEC mRNA and the degree of steatosis. (C) Correlation between 
CIDEC mRNA and MELD score, ABIC score, and HVPG. (D) Hepatic CIDEC mRNA 
levels in alive and deceased AH patients. (E) Hepatic CIDEC mRNA level and 90-day 
mortality. P values are presented in the figure.
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Figure 7. A proposed model for a critical role of FSP27 in chronic-plus-binge ethanol-induced 
ASH
ERS: endoplasmic reticulum stress; LD: lipid droplet.
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